Navigation Links
Cardiologists and heart surgeons meet for 'Controversies and Advances' conference
Date:9/26/2007

LOS ANGELES (September 25, 2007) Stem cell therapy for cardiac regeneration and the controversial issue of medicine and the media will be the focus of the keynote addresses at the seventh annual Controversies and Advances in the Treatment of Cardiovascular Disease conference. Conducted by Cedars-Sinai Medical Center at the Beverly Hills Hotel on Oct. 4 and 5, the conference is co-sponsored by the California Chapter of the American College of Cardiology, the California Chapter of the Society of Thoracic Surgeons, and Promedica International CME.

Professional differences of opinion often have stood between heart surgeons and cardiologists, and recent innovations in minimally invasive medical procedures have done nothing to reduce the friction. The ongoing debate as to whether it is better to replace and repair aortic and mitral valves surgically or to manage them medically is just one example. And when considering treatment options for Atrial Fibrillation, the choices are even more diverse should the physician opt for minimally invasive surgery, drugs or a catheter treatment" And then there is the highly controversial stent issue drug-eluting vs. bare metal which is better"

This major symposium one of the very few that brings together both cardiologists and heart surgeons will directly explore the controversies and latest medical and surgical advances in an open forum. Many subjects will be addressed in debate formats. Others will be lectures presented by highly respected leaders in their fields.

Lawrence K. Altman, M.D., author of the book Who Goes First" The Story of Self-Experimentation in Medicine and a member of the New York Times science news staff since 1969, will be one of two keynote speakers. Altman, senior medical correspondent at the Times, has published an average of 100 scientific stories a year and writes the column Doctors World. His remarks will focus on medicine and the media.

A clinical professor at New
'/>"/>

Contact: Sandy Van
sandy@prpacific.com
800-880-2397
Cedars-Sinai Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. UCSD team discovers specialized, rare heart stem cells in newborns
3. Implanted Devices Detect High-Risk Heart Failure Patients
4. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
5. Special Imaging Study Shows Failing Hearts Are Energy Starved
6. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
7. Single stem cells from bone heal a broken heart
8. Heart repair gets new muscle
9. Python a hearty eater
10. Columbia study shows widely used artery clearing device does not help patients during heart attack
11. Researchers reveal secret of key protein in brain and heart function

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife C... revealing that the last remaining population of S...ue to the rising tide of poaching and habitat loss...form Russian officials of what needs to be done to...est cat. , The report was released ...
(Date:11/23/2009)...w research presents strong evidence that the "syne...door traffic-related pollution and indoor endotoxi... the other exposure alone. , Environmental hea...) College of Medicine have shown that children exp...les and indoor endotoxin during early life are six...
(Date:11/23/2009)...f. -- More than 160 participants gathered this wee...UTURES INITIATIVE conference. This year,s topic, "...ngineers, and medical researchers to explore the e...ing the emerging field of synthetic biology. , B...t Princeton University and this year,s conference ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Leading Biotechnology Company Awards Phase III Cardiac Safety Study to iCardiac 14246 1Leading Biotechnology Company Awards Phase III Cardiac Safety Study to iCardiac 14246 2UMass Boston Researcher Partner Develop Non Invasive Technique for Lead Testing in Humans 58234 1UMass Boston Researcher Partner Develop Non Invasive Technique for Lead Testing in Humans 58234 2UMass Boston Researcher Partner Develop Non Invasive Technique for Lead Testing in Humans 58234 3Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 1Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 2Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 3Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 4
... The way the evangelical movement is defined has ...nto the political spectrum, according to a study b...ty of Texas-Austin. , "In this election year, the...e off enough evangelical votes to carry certain sw... the researchers. "That depends a great deal on wh...
... This release is available in German . , Pl...heir study now published in PLoS Biology, scientis...iology in Tbingen have shown that certain small se...rowth and aging processes in plants. These microRN...ription factors. These transcription factors in tu...
... This year,s Julius Springer Prize for Applied Ph...Heinz for their pioneering work on the electrical ...ls including carbon nanotubes − from basic s...anied by US$ 5,000, will be presented at the Juliu...d University in Cambridge, MA, on 27 September 200...
Other Biology News:New study looks to define evangelicals and how they affect polling 2Formula discovered for longer plant life 2Carbon nanostructures form the future of electronics and optoelectronics 2
(Date:11/27/2009)... , , DURHAM, N.C., Nov. 27 /PRNewsw...Park, will initiate water-soluble carbon nanotube-...dia. The water-soluble carbon nanotubes, which hav...onjugation with cancer drugs, was developed in par.... The conjugated carbon nanotubes serves as a drug...
(Date:11/25/2009)... , , DURHAM, N.C., Nov. 25 /PRNewsw...nveiled the first energy-efficient, single-treatme...d from carbon nanotubes to Andhra Pradesh, Ministe...d other leaders in Hyderabad, India today. Initial...y (IIT) Kanpur, confirmed that the majority of the...
(Date:11/25/2009)... , , MARKHAM, ON, Nov. 25 /PRNewswire/ - ...r Moldt, PhD to its Board of Directors. Dr. Moldt ...sentative on the Company,s Board. The number of Bo..., "We are very pleased to welcome Peter Moldt to t...xperience and guidance as Cytochroma continues to ...
(Date:11/24/2009)... , This release is available in German . ,...ication cards: RFID tags (Radio Frequency Identifi...eryday life. They make it possible to label object...o frequency. The appropriate scanner can read and ...els can be affixed to goods under production condi...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2
...VANCOUVER, June 9 /PRNewswire/ - OncoGenex Technol...th Annual Biotechnology & Medical,Technology Confe...ce Hotel.,OncoGenex, President and Chief Executive...overview at the conference, including an overview ...om the American Society of,Clinical Oncology (ASCO...
...NEW YORK and LONDON, June 9 Paul Capital Healthca...acleod, Ph.D., will moderate,a panel on strategic ...nnovate Europe 08 conference. Designed to familiar...s a strategic approach to financing, the panel,"Fe... Strategy for Meeting,Biotechnology,s Capital Need...
...A Powerful New Tool for Early Identification of Hi...Help Prevent Disease Progression, SAN FRANCISCO, ... the 68th Scientific Sessions of the American Diab...ailability of its novel PreDx(TM) Diabetes,Risk Te...ers an accurate,assessment of an individual,s risk...
Other Biology Technology:OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 2OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 3Paul Capital Healthcare Leads Panel on Strategic Financing 2Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 2Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 3Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 4
RNase AWAY(r) from Sigma-Aldrich
TiterHigh Sf Insect Medium from Sigma-Aldrich
Corning Culture Flask, 25 cm2, Tc-Treated, Straight Neck, Vent Cap, Sterile from Sigma-Aldrich
Schneiders Insect Medium from Sigma-Aldrich
Biology Products: